newsfilter
← Latest News
PR Newswire·

Pulmatrix, Inc. Announces 1-for-20 Reverse Stock Split

LEXINGTON, Mass., Feb. 24, 2022 /PRNewswire/ -- Pulmatrix, Inc. ("Pulmatrix" or the "Company") (NASDAQ:PULM) a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using